Fonte: Journal der deutschen dermatologischen gesellschaft. Unidade: FM
Assuntos: DERMATOPATIAS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SATO-SANO, Marcelo et al. Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib. Journal der deutschen dermatologischen gesellschaft. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/ddg.13704. Acesso em: 30 set. 2024. , 2018APA
Sato-sano, M., Cury-martins, J., Sanches, J. A., Macarenco, R., Domingues, R. B., & Vasconcelos, R. (2018). Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib. Journal der deutschen dermatologischen gesellschaft. Hoboken: Faculdade de Medicina, Universidade de São Paulo. doi:10.1111/ddg.13704NLM
Sato-sano M, Cury-martins J, Sanches JA, Macarenco R, Domingues RB, Vasconcelos R. Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib [Internet]. Journal der deutschen dermatologischen gesellschaft. 2018 ; 16( 12): 1486-1489.[citado 2024 set. 30 ] Available from: https://doi.org/10.1111/ddg.13704Vancouver
Sato-sano M, Cury-martins J, Sanches JA, Macarenco R, Domingues RB, Vasconcelos R. Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib [Internet]. Journal der deutschen dermatologischen gesellschaft. 2018 ; 16( 12): 1486-1489.[citado 2024 set. 30 ] Available from: https://doi.org/10.1111/ddg.13704
